Filter by keyword: Filter by year:

Telemedicine Prescriptions in the Wake of the National COVID-19 Emergency

March 6, 2023

The public health emergency declared by the Department of Health and Human Services due to the COVID-19 outbreak is set to end on May 11,

Recent Developments in AI and Intellectual Property

March 1, 2023

When the framers of the Constitution granted Congress the power “[t]o promote the Progress of Science and useful Arts, by securing for limited Times to

IP Law Makes First Contact With NFTS

February 22, 2023

Non-fungible tokens, commonly referred to as NFTs, exploded in popularity over the last few years, largely as a result of the increased popularity of and

An Interview with ChatGPT: Will AI replace lawyers?

February 14, 2023

The following interview is an unedited interaction between myself and the January 30, 2023 release of ChatGPT, a chatbot developed by OpenAI.[1] In

Spyware Under the ICCPR

February 14, 2023

In 2011, the NSO Group introduced Pegasus into the market to “help[] government agencies prevent and investigate terrorism and crime to save thousands of lives

Political Gerrymandering in Today's Technological Landscape

February 7, 2023

With increasing partisan polarization and reduction in voting across party lines, redistricting schemes implemented by state legislatures are one of the most important tools legislatures

The Potential for Copyright Law as a Helpful Framework for Liability in Medicine

February 6, 2023

Artificial intelligence (AI) and machine learning (ML) models are quickly becoming more common in the medical space. One such use, for example, is a

How Poor Legal Technology at the Supreme Court Leaked the Dobbs Draft and Helped the Perpetrator Get Away

January 30, 2023

Public Report Reveals Outdated Technology at the Supreme Court

On May 2, 2022, Politico reported it had obtained a draft of the Supreme Court’s long-anticipated

AI-Generated Images: The First Lawsuit

January 25, 2023

            On January 13, three artists filed a class-action lawsuit against a number of artificial intelligence (AI) companies, alleging copyright violations arising out of the

The Murky Intellectual Property Future of Schedule I Drugs

January 16, 2023

Cannabis, psilocybin, MDMA, and many other psychoactive drugs remain Schedule I Drugs under the Controlled Substances Act. They remain explicitly illegal at the federal level,